Passage Bio, Inc. (PASG) Reports In-Line Q1 EPS

Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Fed: Governors Hammack, Kashkari and Logan dissented in favor of rate hike
• Wabash National (WNC) Misses Q2 EPS by 3c
• PSQ Holdings (PSQH) Tops Q2 EPS by 33c